| Original language | English |
|---|---|
| Pages (from-to) | 2348-2360 |
| Number of pages | 13 |
| Journal | Clinical Cancer Research |
| Volume | 25 |
| Issue number | 7 |
| DOIs | |
| Publication status | Published - 2019 |
Cite this
An epithelial-to-mesenchymal transcriptional switch triggers evolution of pulmonary sarcomatoid carcinoma (PSC) and identifies dasatinib as new therapeutic option. / Manzotti, G.; Torricelli, F.; Benedetta, D.; Lococo, F.; Sancisi, V.; Rossi, G.; Piana, S.; Ciarrocchi, A.
In: Clinical Cancer Research, Vol. 25, No. 7, 2019, p. 2348-2360.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - An epithelial-to-mesenchymal transcriptional switch triggers evolution of pulmonary sarcomatoid carcinoma (PSC) and identifies dasatinib as new therapeutic option
AU - Manzotti, G.
AU - Torricelli, F.
AU - Benedetta, D.
AU - Lococo, F.
AU - Sancisi, V.
AU - Rossi, G.
AU - Piana, S.
AU - Ciarrocchi, A.
N1 - Cited By :1 Export Date: 13 May 2019
PY - 2019
Y1 - 2019
U2 - 10.1158/1078-0432.CCR-18-2364
DO - 10.1158/1078-0432.CCR-18-2364
M3 - Article
VL - 25
SP - 2348
EP - 2360
JO - Clinical Cancer Research
JF - Clinical Cancer Research
SN - 1078-0432
IS - 7
ER -